Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
due for a pullback, but who knows?
lol.
Who has not discovered BIVI yet? Take a close look....
Everyone take a look. Certainly not selling now.
BIVI already 2x....and headed higher
Stock is up almost 2% on the news
lol! the saga continues, although this is soon to be sub-microscopic
I see this is still hanging by a thread...
gotta get something out there even tho there is nothing new to report. I know! An update on upcoming updates!
truth from the bunny
perhaps the board could pass the hat for Leo's salary.
why end the easy money? There's almost certainly some sort of financing still available. Maybe they could hire Theracour to generate some new ideas ....
So even if they could get .04/share for 250,000,000 shares, their ability to raise more than about $10mm is in serious doubt. That's over 50% dilution. You can forget about any more trials on B unless (until?) the share price somehow rises a fair amount.
how far from a billion outstanding is this turkey?
and, of course, there is the problem of using an antibiotic to treat a viral infection....
trial failure
Okay...close enough to 10 cents for me.
OUT
got in and am already out. could be more upside...possibly 10?
I agree. K and P have the same value....zero.
But what value does B really have?
No way of knowing except that it works decently on ABSSSI.
A drug mired in trial limbo that works on ABSSSI...what is the value? Gotta be at least 100 Million.
many seem to forget this is an antibiotic...BWDIK?
well at least this time they did not try to hide things.
what now?
Holding for trial results with house money only
My guess is $.20 is much more likely, but should there be success the upside is much higher $.40...maybe over a dollar in an initial pop.
Also important is how results are communicated. Clarity helps! Talking subgroups and secondary endpoints is fine but if the primary endpoint is met there needs to be absolute clarity about that...perhaps even outside expertise brought in for support. Any lack of clarity is a big time sell signal.
may have bought at the right time this go round
RIP Govorchin.
It certainly could, but I'm back in on the drop with a small position. It would be nice if we had a better indication of timing. This data could come anytime between now and the end of October...or even later if we get back on "CTIX time"
Was that your buy that pushed it back up?
Thanks MinnieM
Started a while back
thank you.
Thanks. did not know about sucrose. I guess it is a lot easier to join in yelling "conspiracy!" than take a look for yourself
I don't think we have to worry about that anymore....
i don't know about that....would like to see the letter.
who has produced the best analysis of phase 3 trial results?
yes but not quite yet...
wow this is like a reunion...
but it is still good news
not until they are exercised
weren't these option awards?
or were they purchases?